These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32147955)

  • 41. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
    Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
    Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sildenafil in Heart failure (SilHF). An investigator-initiated multinational randomized controlled clinical trial: rationale and design.
    Cooper TJ; Guazzi M; Al-Mohammad A; Amir O; Bengal T; Cleland JG; Dickstein K
    Eur J Heart Fail; 2013 Jan; 15(1):119-22. PubMed ID: 23097067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.
    Schuuring MJ; Vis JC; van Dijk AP; van Melle JP; Vliegen HW; Pieper PG; Sieswerda GT; de Bruin-Bon RH; Mulder BJ; Bouma BJ
    Eur J Heart Fail; 2013 Jun; 15(6):690-8. PubMed ID: 23361871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
    Bharani A; Mathew V; Sahu A; Lunia B
    Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
    Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F
    Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
    Goudie AR; Lipworth BJ; Hopkinson PJ; Wei L; Struthers AD
    Lancet Respir Med; 2014 Apr; 2(4):293-300. PubMed ID: 24717626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is ventilatory efficiency (VE/VCO(2) slope) associated with right ventricular oxidative metabolism in patients with congestive heart failure?
    Ukkonen H; Burwash IG; Dafoe W; de Kemp RA; Haddad H; Yoshinaga K; Davies RA; Gannon EK; Dasilva JN; Beanlands RS
    Eur J Heart Fail; 2008 Nov; 10(11):1117-22. PubMed ID: 18818123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of patients with a relatively greater minimum VE/VCO
    Nakade T; Adachi H; Murata M; Oshima S
    Eur J Appl Physiol; 2018 Aug; 118(8):1547-1553. PubMed ID: 29761310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of a transition education program on health-related quality of life in pediatric patients with congenital heart disease: study design for a randomised controlled trial.
    Werner O; Bredy C; Lavastre K; Guillaumont S; De La Villeon G; Vincenti M; Gerl C; Dulac Y; Souletie N; Acar P; Pages L; Picot MC; Bourrel G; Oude Engberink A; Million E; Abassi H; Amedro P
    Health Qual Life Outcomes; 2021 Jan; 19(1):23. PubMed ID: 33468144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimizing the evaluation of excess exercise ventilation for prognosis assessment in pulmonary arterial hypertension.
    Ferreira EV; Ota-Arakaki JS; Ramos RP; Barbosa PB; Almeida M; Treptow EC; Valois FM; Nery LE; Neder JA
    Eur J Prev Cardiol; 2014 Nov; 21(11):1409-19. PubMed ID: 23787797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term use of sildenafil in the therapeutic management of heart failure.
    Guazzi M; Samaja M; Arena R; Vicenzi M; Guazzi MD
    J Am Coll Cardiol; 2007 Nov; 50(22):2136-44. PubMed ID: 18036451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death.
    Gitt AK; Wasserman K; Kilkowski C; Kleemann T; Kilkowski A; Bangert M; Schneider S; Schwarz A; Senges J
    Circulation; 2002 Dec; 106(24):3079-84. PubMed ID: 12473555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.
    Guazzi M; Labate V; Cahalin LP; Arena R
    Eur J Prev Cardiol; 2014 Jul; 21(7):847-54. PubMed ID: 23382540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute vasodilator testing following Fontan palliation: an opportunity to guide precision care?
    Day RW
    Cardiol Young; 2020 Jun; 30(6):829-833. PubMed ID: 32441233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials.
    Zhuang XD; Long M; Li F; Hu X; Liao XX; Du ZM
    Int J Cardiol; 2014 Apr; 172(3):581-7. PubMed ID: 24534379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern of resolution of pulmonary hypertension, long-term allograft right ventricular function, and exercise capacity in high-risk heart transplant recipients listed under oral sildenafil.
    De Santo LS; Buonocore M; Agrusta F; Bancone C; Galdieri N; Romano G; Maiello C; Amarelli C
    Clin Transplant; 2014 Jul; 28(7):837-43. PubMed ID: 24828060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of cardiac resynchronisation therapy on adaptation of circulatory and respiratory systems to exercise assessed by cardiopulmonary exercise test in patients with chronic heart failure.
    Chwyczko T; Sterliński M; Maciag A; Firek B; Labecka A; Jankowska A; Kośmicki M; Kowalik I; Malczewska B; Szwed H
    Kardiol Pol; 2008 Apr; 66(4):406-12; discussion 413-4. PubMed ID: 18473269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ventilatory variables are strong prognostic markers in elderly patients with heart failure.
    Mejhert M; Linder-Klingsell E; Edner M; Kahan T; Persson H
    Heart; 2002 Sep; 88(3):239-43. PubMed ID: 12181213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial.
    Ulrich S; Saxer S; Hasler ED; Schwarz EI; Schneider SR; Furian M; Bader PR; Lichtblau M; Bloch KE
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31073087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical use of ventilation measurement during early phase of exercise in patients with chronic heart failure].
    Jankowska EA; Witkowski T; Zymliński R; Ponikowska B; Petruk-Kowalczyk J; Szachniewicz J; Reczuch K; Borodulin-Nadzieja L; Banasiak W; Ponikowski P
    Pol Arch Med Wewn; 2004 Mar; 111(3):283-90. PubMed ID: 15230208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.